89 related articles for article (PubMed ID: 2130217)
1. [The immunodeficient mouse (SCID) as an animal model for AIDS].
Pasqualini CD
Medicina (B Aires); 1990; 50(3):272-3. PubMed ID: 2130217
[No Abstract] [Full Text] [Related]
2. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.
Jamieson BD; Aldrovandi GM; Zack JA
Semin Immunol; 1996 Aug; 8(4):215-21. PubMed ID: 8883144
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subsets and abnormalities in retrovirally infected mice.
Popp DM
Crit Rev Immunol; 1990; 10(2):73-112. PubMed ID: 1963783
[No Abstract] [Full Text] [Related]
4. Small animal models for acquired immune deficiency syndrome (AIDS) research.
Mosier DE
Lab Anim Sci; 1996 Jun; 46(3):257-65. PubMed ID: 8799929
[No Abstract] [Full Text] [Related]
5. Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse.
Magee DM; Igietseme JU; Smith JG; Bleicker CA; Grubbs BG; Schachter J; Rank RG; Williams DM
Reg Immunol; 1993; 5(6):305-11. PubMed ID: 7520728
[TBL] [Abstract][Full Text] [Related]
6. Xenogeneic PBL-scid mice: their potential and current limitations.
Greenwood JD
Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
[TBL] [Abstract][Full Text] [Related]
7. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.
Heeney J; Jonker R; Koornstra W; Dubbes R; Niphuis H; Di Rienzo AM; Gougeon ML; Montagnier L
J Med Primatol; 1993; 22(2-3):194-200. PubMed ID: 8105093
[TBL] [Abstract][Full Text] [Related]
8. hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.
Torbett BE; Picchio G; Mosier DE
Immunol Rev; 1991 Dec; 124():139-64. PubMed ID: 1666627
[No Abstract] [Full Text] [Related]
9. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
[TBL] [Abstract][Full Text] [Related]
10. SCID-Hu mouse as a model for human lung HIV-1 infection.
Cesbron JY; Agut H; Gosselin B; Candotti D; Raphaël M; Puech F; Grandadam M; Debré P; Capron A; Autran B
C R Acad Sci III; 1994 Jul; 317(7):669-74. PubMed ID: 7882151
[TBL] [Abstract][Full Text] [Related]
11. Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes.
Ifversen P; Mårtensson C; Danielsson L; Ingvar C; Carlsson R; Borrebaeck CA
Immunology; 1995 Jan; 84(1):111-6. PubMed ID: 7534259
[TBL] [Abstract][Full Text] [Related]
12. Animal model Balamuthia mandrillaris CNS infection: contrast and comparison in immunodeficient and immunocompetent mice: a murine model of "granulomatous" amebic encephalitis.
Janitschke K; Martínez AJ; Visvesvara GS; Schuster F
J Neuropathol Exp Neurol; 1996 Jul; 55(7):815-21. PubMed ID: 8965096
[TBL] [Abstract][Full Text] [Related]
13. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
14. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases.
Vladutiu AO
Clin Exp Immunol; 1993 Jul; 93(1):1-8. PubMed ID: 8324894
[TBL] [Abstract][Full Text] [Related]
15. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
Chen FA; Williams SS; Fanslow WC; Bankert RB
J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
[TBL] [Abstract][Full Text] [Related]
16. HIV hollow fiber SCID model for antiviral therapy comparison with SCID/hu model.
Taggart BR; Harrington P; Hollingshead M
Antiviral Res; 2004 Jul; 63(1):1-6. PubMed ID: 15196814
[TBL] [Abstract][Full Text] [Related]
17. Clonal outgrowths of T and B cells in SCID mice reconstituted with cells from mice with MAIDS.
Tang Y; Chattopadhyay SK; Hartley JW; Fredrickson TN; Morse HC
In Vivo; 1994; 8(6):953-9. PubMed ID: 7772747
[TBL] [Abstract][Full Text] [Related]
18. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
19. Human T-and B-cell functions in SCID-hu mice.
Roncarolo MG; Carballido JM; Rouleau M; Namikawa R; de Vries JE
Semin Immunol; 1996 Aug; 8(4):207-13. PubMed ID: 8883143
[TBL] [Abstract][Full Text] [Related]
20. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
